|
NEWS, EVENTS, and DEADLINES
May 11, 2023
| |
NJ ACTS TL1 Fellows Take Top Honors
at the ACTS Annual Conference
This year's ACTS conference was held in Washington, DC. NJ ACTS had three TL1 Fellows that took top honors. We congratulate them on their achievements!
| |
|
Courtney McDermott was named the ACTS Outstanding Trainee for the Pre-Doctoral Scholar Award.
McDermott is exploring "Early life antibiotic exposure and genetic risk in neurodevelopmental disorders: Effects on the gut microbiome, neurogenesis, and behavior".
| |
|
Andrew Guarnaccia is a Post-Doctoral Scholar exploring "Cancer treatment using CD/5-fluorocytosine (5-FC) GDEPT".
Guarnaccia received a first place ribbon for his poster presentation, scoring the highest possible rating from all the judges!
| |
Sarah Lundell is a Pre-Doctoral Scholar exploring "Mechanisms regulating differential transmissibility of clinical strains of Mycobacterium tuberculosis".
Lundell received a first place ribbon for her poster presentation, scoring the highest possible rating from all the judges!
| |
NJ ACTS Workforce Core Interns' Success
Acknowledged by Senator Cory Booker
Our most recent Workforce Development Interns' success at the ACTS Conference in 2023 has been recognized by Senator Cory Booker! Senator Booker mailed a letter to each of the interns that presented a poster at the ACTS Conference.
View Letter
| |
Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events | |
NJ ACTS Biostatistics and Epidemiology Workshop Series
An Introduction to AI Techniques for Forecasting Epidemic Dynamics
| |
Lijing Wang, PhD
Assistant Professor, Data Science, NJIT
May 12, 2023
1 - 2 pm
This workshop covers the state-of-the-art for epidemic forecasting. It starts with a formal definition of an epidemic process and details the different aspects of disease spread dynamics.
View Flyer
| |
|
Screen NJ - Cancer Screening Learning Series
Please join us for a new quick learning series on the biology and best practices for cancer screening, early detection, and treatment of breast, colon, liver, and lung cancer! Sessions also include genetic assessment/testing to improve both cancer screening and treatment approaches, as well as how to use cancer screening patient education and marketing materials designed by and for Black/African American and Hispanic/Latina women.
View Flyer for Details
Sessions Available in throughout May
| |
These programs are open to anyone who has direct contact with patients (including community health workers and others who work with clients and community members and may refer or link people to cancer prevention and screening services). | |  |
|
Each session will be 30 minutes of
dialogue with 10 min of Q&A.
No preregistration is required.
| |
|
Barbara DeMarco, PhD
Associate Dean for Academic Affairs
Rutgers School of Public Health
May 15, 2023
12 - 1 pm
| |
|
Questions?
Contact Mark DeGuzman
Coordinator
NSF I-Corps Hub
| |
|
NOVUS I-Corps
Introductory Workshop
Join I-Corps for training and networking. Learn how to change your focus from the science and technology to the people it benefits!
Read more
May 18, 2023
9 am - 1pm
| |
Propelus I-Corps
4-Week Program
Enables research teams of 2+ to explore the market potential for an innovation as well as how the technology can create value for a specific customer segment.
Read more
The program is in June, but the application deadline is May 15th.
| |
|
|
|
NJ ACTS Special Populations Core
2023 Seminar Series
Incarceration, Health, and the Life Course
Nathan Link, PhD
May 24, 2022
1 - 2 pm
Professor Link will discuss his research on the connections between incarceration and health, including how mental and physical health states impact life transitions including development into adulthood and reentry from prison.
View Flyer
| | | |
|
Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) $175M 2023 Appropriation
For fiscal year 2023 TBIPHRP is offering a range of mechanisms to accommodate research across the development spectrum. In addition, several mechanisms offer support for independent investigators of all levels.
See Flyer for Details
| |
|
The NJACTS Scientific Review Board supports investigator-initiated studies by reviewing non-oncology protocols to assess proper statistical design, enrollment goals, feasibility (including adequate research staffing, competing trials, funding, resources, and departmental support) to help accelerate IRB approval and to help ensure study success. Learn more the SRB Process
| |
National Institutes of Health (NIH) | | |
|
The National Institutes of Health's All of Us Research Program has expanded its data to include nearly a quarter million whole genome sequences for broad research use. Read more! | |
|
Non-prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder. Williams, Arthur Robin; Mauro, Christine M.; Feng, Tianshu; Wilson, Amanda; Cruz, Angelo; et al. Journal Of Substance Abuse Treatment. 2022 Aug;139:108770. doi:10.1016/j.jsat.2022.108770.Epub 2022 Mar 21.
Mechanism-driven modeling of chemical hepatotoxicity using structural alerts and an in vitro screening assay. Jia, Xuelian; Wen, Xia; Russo, Daniel P.; Aleksunes, Lauren M.; Zhu, Hao. Journal Of Hazardous Materials. 2022 Aug 15; 436:129193.doi:10.1016/ j.jhazmat.2022.129193.Epub 2022 May 20.
| |
Community Engagement Virtual Salons-provide a structured approach to engaging members of the community for their meaningful guidance and input on specific research ideas or studies. Request a Consultation Here! | |
Build a Successful Collaboration with NJ ACTS Team Science - The Team Science Core offers general and project-specific consultations on building and maintaining successful research teams and collaborations. To set up a consultation, please fill out the intake form. Read more about the Team Science Core. | |
NJ ACTS is a partnership between Rutgers, NJIT and Princeton. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health. | |
This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UL1TR003017 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.
New Jersey Alliance for Clinical and Translational Science
89 French St., Suite 4211
New Brunswick, NJ
Copyright 2020 New Jersey Alliance for Clinical and Translational Science, all rights reserved
UL1TR003017, KL2TR003018 and TL1TR003019
| | | | |
